Development of a risk score for patients with ischaemic cardiomyopathy - 11/03/23
, Guillermo Romero-Farina b, c, 1, Lorena Herrador a, Pablo Jordán a, Carina Espinet-Coll b, María Nazarena Pizzi a, c, Aida Ribera a, d, Ignacio Ferreira-González a, d, Santiago Aguadé-Bruix b, c
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Highlights |
• | Risk score predicts risk of MACE in patients with ischaemic cardiomyopathy. |
• | Risk score comprises eight readily available variables. |
• | The risk score's ease of use may allow its implementation in clinics. |
Abstract |
Background |
Ischaemic cardiomyopathy is a leading cause of heart failure and is associated with a poor prognosis.
Aim |
To evaluate predictors of major adverse cardiovascular events (MACE) and to develop a risk score for the disease.
Methods |
All patients with ischaemic cardiomyopathy referred to a tertiary hospital between 2010 and 2018 for stress-rest gated single-photon emission computed tomography (SPECT) were included retrospectively (n=747). Clinical and gated SPECT-derived variables were analysed as predictors of MACE, a combined endpoint of cardiovascular mortality, heart failure hospitalization or myocardial infarction during follow-up. A multivariable Cox model using backwards stepwise regression with competing risks was used to select the best parsimonious model.
Results |
After a median follow-up of 4.7 years, 313 patients had MACE (41.9%). Independent predictors of MACE were previous heart failure admission, worsening angina or dyspnoea, estimated glomerular filtration rate ≤60mL/min/1.73 m2, age>73 years, diabetes, atrial fibrillation, end-diastolic volume index>83mL/m2 and>12% of scarred myocardium. A risk score ranging from 0 to 12 classified patients as at intermediate risk (event rate of 4.0 MACE per 100 person-years), high risk (11.3 MACE per 100 person-years) or very high risk (27.8 MACE per 100 person-years). The internally validated area under the curve was 0.720 (95% confidence interval 0.660–0.740) and calibration was adequate (Hosmer-Lemeshow test P=0.28) for MACE.
Conclusions |
In patients with ischaemic cardiomyopathy, a simple risk score using dichotomic and readily available variables obtained from clinical assessment and gated SPECT accurately predicts the risk of MACE.
El texto completo de este artículo está disponible en PDF.Keywords : Risk score, Ischaemic cardiomyopathy, SPECT, Prognosis
Abbreviations : AUC, CI, HF, HR, ICM, LVEF, MACE, SPECT
Esquema
| ☆ | Tweet: A simple clinical score comprising HF admission, worsening symptoms, eGFR <60ml/min/1.73 m2, >73 years, DM, AF, EDVi >83ml/m2 and >12% scar accurately predicts MACE in ICM (AUC=0.720). |
Vol 116 - N° 3
P. 145-150 - mars 2023 Regresar al número
Artículo precedente
- Initiation and development of a percutaneous left atrial appendage closure programme: A French centre's experience and literature review
- Emeric Albert, Tania Puscas, Gabriel Seret, Noémie Tence, Denis Amet, Emilie Varlet, Dorra Raboudi M’Barek, Fabien Picard, Akli Otmani, Laurent Sabbah, Julien Le Guen, Eric Bodiguel, Valerie Domigo, Gilles Soulat, Christian Spaulding, Eloi Marijon
- Clinical significance of myocardial contraction fraction in significant primary mitral regurgitation
- Alexandre Altes, Jérémy Bernard, Hélène Dumortier, Marlène Dupuis, Oumhani Toubal, Haïfa Mahjoub, Jean Tartar, Nancy Côté, Marie-Annick Clavel, Kim O’Connor, Mathieu Bernier, Jonathan Beaudoin, André Vincentelli, Philippe Pibarot, Sylvestre Maréchaux
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.